Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 152.71B, Pfizer(PFE) trades at $26.89. The stock has a price-to-earnings ratio of 19.75 and currently yields dividends of 6.4%.
During the trading session on 2026-02-20, Pfizer(PFE) shares reached a daily high of $27.40 and a low of $26.58. At a current price of $26.89, the stock is +1.2% higher than the low and still -1.9% under the high.
Trading volume for Pfizer(PFE) stock has reached 40.32M, versus its average volume of 45.11M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.94 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.94 and a low of $20.92.
PFE News
Key Points Pfizer has reached a transition point following declines of some of its biggest blockbusters. The pharma giant is paving the way to growth through...
Barclays analyst Emily Field initiated coverage of Pfizer (PFE) with an Underweight rating and $25 price target Pfizer is “managing through a difficult period,”...
Pfizer (NYSE:PFE) reported positive pivotal Phase 3 trial results for BRAFTOVI in combination with cetuximab and FOLFIRI in BRAF V600E-mutant metastatic colorec...
Analyst ratings
59%
of 29 ratingsMore PFE News
If you are looking for high-yield stocks, these two turnaround stories offer yield and green shoots, suggesting better times are ahead. The U.S. market appears...
Pfizer Inc. is drawing on lessons learned years ago from rolling out Viagra as it maps out the launch of its first obesity medicine. The parallels between weig...
Mixed options sentiment in Pfizer (PFE), with shares down 6c near $27.32. Options volume relatively light with 33k contracts traded and calls leading puts for a...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is launching a new real-world study in Taiwan to track how its multiple...
Pfizer reported positive pivotal results from its BREAKWATER trial for the BRAFTOVI based regimen in first line treatment of BRAF V600E mutant metastatic colore...
Pfizer Inc. (NYSE:PFE) on Tuesday shared news regarding its BRAFTOVI regimen for treating metastatic colorectal cancer. Pfizer announced that its Braftovi regi...
Pfizer (PFE) announced on Tuesday that its colorectal cancer therapy, Braftovi, as part of a combination regimen, improved patient survival, reaching a key seco...
